Antimicrobial peptides and self-DNA in autoimmune skin inflammation

Current Opinion in Immunology

Volumn 20, Issue 4, 2008, Pages 401-407

  Gilliet, Michel ^a   Lande, Roberto ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; VIRUS DNA; VIRUS RNA;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; DNA FRAGMENTATION; GENE OVEREXPRESSION; HUMAN; IMMUNE RESPONSE; MOLECULAR SENSOR; NONHUMAN; PATHOGENESIS; PROTEIN BINDING; PROTEIN FUNCTION; PSORIASIS; REVIEW; SKIN INJURY; VIRUS INFECTION;

ANTIMICROBIAL CATIONIC PEPTIDES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DENDRITIC CELLS; DEOXYRIBOSE; DNA; DNA, VIRAL; HUMANS; INFLAMMATION; INTERFERON TYPE I; PSORIASIS; SELF TOLERANCE; SKIN; TOLL-LIKE RECEPTOR 9;

EID: 48549088455     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2008.06.008     Document Type: Review

References (55)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23 (2005) 275-306
3. Lande R., Gregorio J., Facchinetti V., Chatterjee B., Wang Y.H., Homey B., Cao W., Wang Y.H., Su B., Nestle F.O., et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449 (2007) 564-569. This paper demonstrates that the endogenous antimicrobial peptide LL37 breaks innate tolerance to self-DNA and launches TLR9 activation of pDCs in psoriasis.
4. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., and Liu Y.J. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194 (2001) 863-869
5. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
6. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
7. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
8. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., and Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 284 (1999) 1835-1837
9. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
10. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., and Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434 (2005) 1035-1040. This study first demonstrated that prolonged TLR9 activation in early endocytic compartments is required for robust type I IFN production by pDCs.
11. Theofilopoulos A.N., Baccala R., Beutler B., and Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23 (2005) 307-336
12. Le Bon A., Etchart N., Rossmann C., Ashton M., Hou S., Gewert D., Borrow P., and Tough D.F. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4 (2003) 1009-1015
13. Marrack P., Kappler J., and Mitchell T. Type I interferons keep activated T cells alive. J Exp Med 189 (1999) 521-530
14. Tough D.F., Borrow P., and Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272 (1996) 1947-1950
15. Gerosa F., Gobbi A., Zorzi P., Burg S., Briere F., Carra G., and Trinchieri G. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174 (2005) 727-734
16. Jego G., Palucka A.K., Blanck J.P., Chalouni C., Pascual V., and Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19 (2003) 225-234
17. Pisetsky D.S., and Fairhurst A.M. The origin of extracellular DNA during the clearance of dead and dying cells. Autoimmunity 40 (2007) 281-284
18. Stacey K.J., Young G.R., Clark F., Sester D.P., Roberts T.L., Naik S., Sweet M.J., and Hume D.A. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol 170 (2003) 3614-3620
19. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20 (2002) 709-760
20. Haas T., Metzger J., Schmitz F., Heit A., Müller T., Latz E., and Wagner H. The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation. Immunity 28 (2008) 315-323. This paper shows that TLR9 recognizes the sugar backbone of natural DNA including self-DNA.
21. Napirei M., Karsunky H., Zevnik B., Stephan H., Mannherz H.G., and Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genetics 25 (2000) 177-181
22. Yasutomo K., Horiuchi T., Kagami S., Tsukamoto H., Hashimura C., Urushihara M., and Kuroda Y. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genetics 28 (2001) 313-314
23. Lee H.K., Lund J.M., Ramanathan B., Mizushima N., and Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315 (2007) 1398-1401
24. Barton G.M., Kagan J.C., and Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self-DNA but facilitates access to viral DNA. Nat Immunol 7 (2006) 49-56. This paper demonstrates that the intracellular location of TLR9 represents a barrier that prevents recognition of self-DNA.
25. Barrat F.J., Meeker T., Gregorio J., Chan J.H., Uematsu S., Akira S., Chang B., Duramad O., and Coffman R.L. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202 (2005) 1131-1139
26. Yasuda K., Yu P., Kirschning C.J., Schlatter B., Schmitz F., Heit A., Bauer S., Hochrein H., and Wagner H. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J Immunol 174 (2005) 6129-6136
27. Ronnblom L., Eloranta M.L., and Alm G.V. Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 36 (2003) 463-472
28. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., and Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Investig 115 (2005) 407-417
29. Blanco P., Palucka A.K., Gill M., Pascual V., and Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294 (2001) 1540-1543
30. Lowes M.A., Bowcock A.M., and Krueger J.G. Pathogenesis and therapy of psoriasis. Nature 445 (2007) 866-873
31. Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., Burg G., Liu Y.J., and Gilliet M. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202 (2005) 135-143. This study demonstrates that pDCs in psoriatic skin initiate autoimmune skin inflammation and disease formation through the production of type I IFNs.
32. Pauluzzi P., Kokelj F., Perkan V., Pozzato G., and Moretti M. Psoriasis exacerbation induced by interferon-alpha. Report of two cases. Acta Derm Venereol 73 (1993) 395
33. Hida S., Ogasawara K., Sato K., Abe M., Takayanagi H., Yokochi T., Sato T., Hirose S., Shirai T., Taki S., et al. CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity 13 (2000) 643-655
34. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
35. Oppenheim J.J., and Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17 (2005) 359-365
36. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75 (2004) 39-48
37. De Y., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., and Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192 (2000) 1069-1074
38. Elssner A., Duncan M., Gavrilin M., and Wewers M.D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J Immunol 172 (2004) 4987-4994
39. Kubo T., and Fujii M. Specific binding and stabilization of DNA and phosphorothioate DNA by amphiphilic alpha-helical peptides. Nucleosides Nucleotides Nucleic Acids 20 (2001) 1313-1316
40. Sandgren S., Wittrup A., Cheng F., Jonsson M., Eklund E., Busch S., and Belting M. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem 279 (2004) 17951-17956
41. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8 (2007) 487-496
42. Dorschner R.A., Pestonjamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., Agerberth B., Gudmundsson G.H., and Gallo R.L. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 117 (2001) 91-97
43. Aberg K.M., Man M.Q., Gallo R.L., Ganz T., Crumine D., Brown B.E., Choi E.U., Kim D.K., Schroder J.M., Feingold K.R., et al. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 128 (2007) 917-925
44. Schauber J., Dorschner R.A., Coda A.B., Buchau A.S., Liu P.T., Kiken D., Helfrich Y.R., Kang S., Elalieh H.Z., Steinmeyer A., et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Investig 117 (2007) 803-811
45. Peyssonnaux C., Boutin A.T., Zinkernagel A.S., Datta V., Nizet V., and Johnson R.S. Critical role of HIF-1alpha in keratinocyte defense against bacterial infection. J Invest Dermatol (2008) March 6. [Epub ahead of print]
46. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., and Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97 (2001) 3951-3959
47. Yamasaki K., Schauber J., Coda A., Lin H., Dorschner R.A., Schechter N.M., Bonnart C., Descargues P., Hovnanian A., and Gallo R.L. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 20 (2006) 2068-2080
48. Yamasaki K., Di Nardo A., Bardan A., Murakami M., Ohtake T., Coda A., Dorschner R.A., Bonnart C., Descargues P., Hovnanian A., et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea [see comment]. Nat Med 13 (2007) 975-980. This paper shows that increased serine protease activity results in increased levels of LL37 and derivatives, which are associated with skin inflammation in acne rosacea patients.
49. Heilborn J.D., Nilsson M.F., Kratz G., Weber G., Sorensen O., Borregaard N., and Stahle-Backdahl M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Investig Dermatol 120 (2003) 379-389
50. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H., and Gudmundsson G.H. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272 (1997) 15258-15263
51. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., and Sabat R. IL-22 increases the innate immunity of tissues. Immunity 21 (2004) 241-254
52. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., and Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
53. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
54. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., and Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
55. Nair R.P., Ruether A., Stuart P.E., Jenisch S., Tejasvi T., Hiremagalore R., Schreiber S., Kabelitz D., Lim H., Voorhees J.J., et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol (2008) January 24 [Epub ahead of print]